Indapamide Cf

Indapamide, the active ingredient in Indapamide Cf, is a thiazide-like diuretic presented as a tablet for oral use. It treats hypertension and edema associated with heart failure, renal or hepatic disease in adult patients.

GNH USA supplies Indapamide Cf as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Indapamide is a thiazide‑like diuretic used to manage conditions related to fluid overload and elevated blood pressure.

Hypertension: lowers systolic and diastolic pressure in essential hypertension. Edema associated with heart failure: promotes diuresis to reduce fluid accumulation in congestive heart failure. Edema due to renal disease: facilitates fluid removal in patients with renal‑related edema. Edema due to hepatic disease: assists in decreasing ascites and peripheral edema in liver disease.

Indapamide may cause a range of adverse reactions, from mild to serious. Monitoring and patient education are essential to manage these effects.

Common Side Effects: - Dizziness or light‑headedness - Headache - Increased urinary frequency - Electrolyte imbalance, especially low potassium - Mild gastrointestinal discomfort

Serious or Rare Side Effects: - Severe dehydration - Significant electrolyte disturbances (hypokalemia, hyponatremia) - Acute kidney injury - Allergic reactions such as rash or angioedema - Blood dyscrasias (e.g., agranulocytosis) - Marked hypotension

Before initiating Indapamide Cf, several safety considerations should be observed.

Monitor electrolytes: regular blood tests to assess potassium and sodium levels. Assess renal function: evaluate kidney function prior to therapy. Use caution in elderly: increased sensitivity to blood pressure changes. Avoid concurrent use with other potent diuretics: risk of excessive fluid loss. Store at ambient temperature: keep below 25°C in the original pack, protect from moisture.

Indapamide Cf can interact with several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Lithium: may increase lithium toxicity. - ACE inhibitors or ARBs: risk of severe hypotension and renal impairment. - NSAIDs: may reduce diuretic efficacy and impair renal function.

Moderate Interactions (Monitor Closely): - Other thiazide or thiazide‑like diuretics: additive electrolyte loss. - Antidiabetic agents: may enhance hypoglycemic effect. - Corticosteroids: may increase risk of hypokalemia.